| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(89)90956-2 |
| P8608 | Fatcat ID | release_mmun4b3jyfbm5pilg364ehdxjq |
| P698 | PubMed publication ID | 2571865 |
| P2093 | author name string | S A Gruber | |
| R B Sothern | |||
| W J Hrushesky | |||
| A Z Bluming | |||
| P433 | issue | 8669 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | menstruation | Q12171 |
| P304 | page(s) | 949-952 | |
| P577 | publication date | 1989-10-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Menstrual influence on surgical cure of breast cancer | |
| P478 | volume | 2 |
| Q36116472 | Body weight and vascular invasion in post-menopausal women with breast cancer |
| Q41117005 | Both estradiol and tamoxifen decrease proliferation and invasiveness of cancer cells transfected with a mutated estrogen receptor |
| Q61900272 | Breast cancer and timing of surgery during menstrual cycle: a 5‐year analysis of 248 premenopausal women |
| Q36292533 | Cell proliferation measured by MIB1 and timing of surgery for breast cancer |
| Q34285969 | Chains of evidence, mosaics of data: does estrogen 'cause' breast cancer? How would we know? |
| Q67799207 | Chronotherapeutics: Implications for drug therapy |
| Q43748478 | Correlation between timing of surgery in relation to the menstrual cycle and prognosis of premenopausal breast cancer patients. |
| Q40552353 | Creation of a stable mammary tumor cell line that maintains fertility-cycle tumor biology of the parent tumor |
| Q40684734 | Current management of carcinoma of the breast |
| Q33758808 | Does breast cancer exist in a state of chaos? |
| Q36959432 | Does iron have a role in breast cancer? |
| Q35128737 | Does the timing of breast cancer surgery in pre-menopausal women affect clinical outcome? An update |
| Q63302055 | Effect of menstrual phase on cell proliferative rate of breast cancer |
| Q72681312 | Effect of menstrual phase on surgical treatment of breast cancer |
| Q71789801 | Effect of timing of surgery during the menstrual cycle of premenopausal breast cancer patients |
| Q37345175 | Estrous cycle modulates ovarian carcinoma growth. |
| Q33871661 | Exploiting the critical perioperative period to improve long-term cancer outcomes |
| Q62497094 | Expression of genes that contribute to proliferative and metastatic ability in breast cancer resected during various menstrual phases |
| Q47628540 | Fertility maintenance and 5-fluorouracil timing within the mammalian fertility cycle |
| Q41085418 | Increased surgery-induced metastasis and suppressed natural killer cell activity during proestrus/estrus in rats |
| Q36136368 | Increased susceptibility to metastasis during pro-oestrus/oestrus in rats: possible role of oestradiol and natural killer cells |
| Q40495582 | Infections related to the menstrual cycle. A study of five otherwise healthy women with recurrent abscesses and a reviw of the literature |
| Q73409046 | Lack of correlation between timing of surgery in relation to the menstrual cycle and prognosis of premenopausal patients with early breast cancer |
| Q38523644 | Lunar phases and survival of breast cancer patients--a statistical analysis of 3,757 cases |
| Q24796121 | Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour |
| Q40751734 | Menses and breast cancer: does timing of mammographically directed core biopsy affect outcome? |
| Q33561220 | Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 study |
| Q73793905 | Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI |
| Q73033937 | Menstrual phase and breast cancer surgery: influence on clinical outcome or pitfall of statistical analysis? |
| Q68640735 | Menstrual status and breast cancer surgery |
| Q41749490 | Menstrual timing of breast cancer surgery |
| Q33262921 | Modeling biological rhythms in failure time data |
| Q34621988 | Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk |
| Q38788375 | Peri-operative biology in primary breast cancer: a credible therapeutic target |
| Q36713318 | Perioperative endocrine status and prognosis in early breast cancer |
| Q47725947 | Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients |
| Q73834259 | Premenopausal status accelerates relapse in node positive breast cancer: hypothesis links angiogenesis, screening controversy |
| Q36277982 | Progesterone regulates the proliferation of breast cancer cells - in vitro evidence |
| Q28709320 | Promising development from translational or perhaps anti-translational research in breast cancer |
| Q37342761 | Surgery as a double-edged sword: a clinically feasible approach to overcome the metastasis-promoting effects of surgery by blunting stress and prostaglandin responses |
| Q37733633 | The Impact of the Menstrual Cycle on Perioperative Bleeding in Vitreoretinal Surgery. |
| Q36525832 | The Relationship between Surgery and Phase of the Menstrual Cycle Affects Survival in Breast Cancer |
| Q46065849 | The effect of surgical timing within the fertility cycle on breast cancer outcome |
| Q35978381 | The phase of the menstrual cycle has no influence on the disease-free survival of patients with mammary carcinoma |
| Q36679506 | The timing of breast cancer surgery within the menstrual cycle |
| Q98386330 | Timing of breast cancer surgery during the menstrual cycle-is there an optimal time of the month? |
| Q36608823 | Timing of breast cancer surgery in relation to menstrual cycle phase: no effect on 3-year prognosis: the ITS Study |
| Q37157588 | Timing of breast cancer surgery in relation to the menstrual cycle--the rise and fall of a hypothesis |
| Q24234561 | Timing of breast surgery in premenopausal breast cancer patients |
| Q68299182 | Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer |
| Q73819928 | Timing of surgery during the menstrual cycle and prognosis of breast cancer |
| Q33538451 | Timing of surgery for primary breast cancer with regard to the menstrual phase and prognosis |
| Q44893090 | Timing of surgery in relation to the menstrual cycle and its influence on the survival of Japanese women with operable breast cancer |
| Q33779172 | Timing of surgery with regard to the menstrual cycle in women with primary breast cancer |
| Q36621686 | Timing within the oestrous cycle modulates adrenergic suppression of NK activity and resistance to metastasis: possible clinical implications |
| Q97566222 | Tumor Excision as a Metastatic Russian Roulette: Perioperative Interventions to Improve Long-Term Survival of Cancer Patients |
| Q37014076 | Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures |
| Q36115058 | Vascular endothelial growth factor in premenopausal women--indicator of the best time for breast cancer surgery? |
| Q37672776 | When should the immune clock be reset? From circadian pharmacodynamics to temporally optimized drug delivery |
Search more.